Le Lézard
Classified in: Science and technology, Business, Covid-19 virus
Subject: SBS

Some Fortune 500 Companies Slowing Payments; Further Threatens Economy


ALLENTOWN, Pa., April 24, 2020 /PRNewswire/ -- In difficult times, we expect our largest corporations to behave responsibly and set a good example. For some of these companies, however, their actions appear to be deepening the economic impact of the COVID-19 pandemic on their suppliers. The latest payment trend analysis from Creditsafe, the Allentown based global business intelligence experts, has shown that, on average, Fortune 500 companies are increasingly delaying payments to their suppliers.

Research by Creditsafe's team of data scientists shows that overall Fortune 500 companies have seen their Days Beyond Terms (DBT) increase by 12% to 13.5 DBT, compared the same period a year ago. DBT is a metric used by commercial credit reference agencies to evaluate a company's payment behavior; it shows how long payments are delayed beyond the agreed date. The data also shows that some companies are now paying more than 90 days beyond agreed terms.

Matthew Debbage, CEO of Creditsafe Americas and Asia, said he is disappointed by these revelations. "While it is understandable that businesses will want to try and control their cash flow in challenging times, companies, especially the larger and more profitable ones, such as those in the Fortune 500 list, should step up and look at the bigger picture. By choosing to delay payments to their suppliers, they are hampering those, often smaller or medium-sized enterprises, from operating effectively. Many businesses are facing significant struggles at the moment, and they don't need businesses holding back payment, making matters worse for everyone," Debbage added.

Creditsafe has recently developed its new COVID-19 Impact Score, gauging the likely impact the pandemic will have on individual businesses and, when used alongside the company's core credit score to help business owners and finance professionals make better decisions in the current climate. The COVID-19 Impact Score measures the potential impact to a business using a scale from A to E, A being the lowest impact, and E severely impacted.

The current pandemic is affecting many businesses to differing degrees, and Creditsafe's analysis shows that this is not always reflected in payment behavior. Some industries, such as large grocery store chains, have even reduced their DBT, paying significantly faster than a year ago. When the Fortune 500 companies' payment behavior is viewed alongside their COVID-19 Impact scores, there are even more startling results. 

"Our analysis suggests that more than 30% of Fortune 500 companies will face a significant impact during the COVID-19 pandemic. We see that these affected companies have already significantly slowed payments by up to 70% when compared to last year," commented Debbage. "However, what was shocking for me was to see companies deemed to face low impact, worsening their payment performance, with some of those companies paying up to 50 days beyond agreed terms. This is deplorable at the best of times, but, it is now wholly unacceptable, and these companies should be doing more to help their suppliers, and in turn, the entire US economy. 

For more information on Creditsafe's COVID-19 Impact Score, as well as to get complimentary access to Creditsafe's Stay Safe program visit https://www.creditsafe.com/stay-safe 

SOURCE Creditsafe


These press releases may also interest you

at 09:05
...

at 09:00
Coveo , a leading provider of enterprise AI Search, Recommendations and Generative Experience platforms that enable individualized, connected, and trusted digital experiences at scale with unified relevance, today announced two new GenAI business...

at 08:49
Cove Capital Investments reviews and analyzes nearly every type of asset class available for Delaware Statutory Trust investors.  This list of potential DST property asset classes includes government leased buildings, self-storage facilities,...

at 08:40
The "United States Self-Monitoring Blood Glucose Devices Market Growth, Share, Size, Trends, Analysis and Forecast (2024 - 2032)" report has been added to ResearchAndMarkets.com's offering. The U.S. Self-Monitoring Blood Glucose Devices market size...

at 08:35
Arch Insurance North America (Arch), a provider of specialized insurance and risk management solutions, today unveiled its latest products available through the Arch APEX? digital platform. Participant Accident coverage is now available for child...

at 08:35
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Vemlidy® (tenofovir alafenamide) 25 mg tablets as a once-daily treatment for chronic hepatitis B...



News published on and distributed by: